RTI Surgical Acquires Optecure Bone Graft Product from Exactech

July 13, 2021

RTI Surgical has entered a long-term strategic agreement with Exactech and acquired Optecure, a 510(k)-cleared demineralized bone matrix product used as a bone graft extender. The product acquisition expands RTI Surgical’s biologic bone substitute portfolio while allowing Exactech to focus on its core joint replacement business.

Buyers
RTI Surgical
Targets
Optecure (Exactech product)
Sellers
Exactech
Industry
Medical Devices
Location
Florida, United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.